# Hitoshi Nakagama

Source: https://onco.cc/people/nakagama-hitoshi/  
OnCo record `nakagama-hitoshi` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Leads Japan's national cancer centre, the hub of the country's genomic medicine and early-phase trial programmes.

## Summary

Hitoshi Nakagama is President of the National Cancer Center Japan, the hub of the country's genomic medicine and early-phase trial programmes. A molecular carcinogenesis researcher, he oversees the centre's hospitals in Tokyo and Kashiwa, its research institute, and national programmes such as SCRUM-Japan and cancer genomic medicine built on comprehensive genomic profiling. His publications include a study of how the tumour-suppressive microRNA miR-34a induces senescence-like growth arrest through the E2F pathway in colon cancer cells, and a review of fatty pancreas as a possible risk factor for pancreatic cancer. His interests span cancer research leadership, prevention and molecular carcinogenesis.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: President, National Cancer Center Japan
- Specialisms: Cancer research leadership; Cancer prevention; Molecular carcinogenesis

## Sources

- National Cancer Center Japan: https://www.ncc.go.jp/en/
- PubMed author search: https://pubmed.ncbi.nlm.nih.gov/?term=Nakagama%20H%5BAuthor%5D%20National%20Cancer%20Center

## Connected records

- technologies: [Comprehensive genomic profiling](https://onco.cc/technologies/cgp/)
- institutions: [National Cancer Center Hospital](https://onco.cc/institutions/ncc-japan/)
- journals: [Cancer science](https://onco.cc/journals/cancer-science/)

---
JSON: https://onco.cc/api/v1/entities/nakagama-hitoshi.json